Diferencia entre revisiones de «Factor V Leiden»
| (No se muestran 2 ediciones intermedias del mismo usuario) | |||
| Línea 11: | Línea 11: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Increased clotting DDX}} | |||
==Evaluation== | ==Evaluation== | ||
| Línea 33: | Línea 33: | ||
<references/> | <references/> | ||
[[Category: | [[Category:Heme/Onc]] | ||
Revisión actual - 05:15 25 ene 2021
Background
- Also known as Factor V Leiden Deficiency or FVL
- Point mutation in FV making it resistant to cleavage by activated protein C
- Increased risk of thrombosis
- Most individuals with FVL will never have a venous thromboembolism (VTE)
Clinical Features
- Family history of thrombophilia
- VTE at a young age
- VTE in an atypical location